Charles River Labs Intl buy UBS Group AG
Start price
08.08.24
/
50%
€184.90
Target price
08.08.25
€220.15
Performance (%)
-5.00%
Price
11.09.24
€175.65
Summary
This prediction is currently active. With a performance of -5.00%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 08.08.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | 2.063% | 2.063% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $290.00 to $240.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€269.47
15.02.25
15.02.25
-22.89%
11.09.24
11.09.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
10.51%
11.09.24
11.09.24